Results 181 to 190 of about 72,449 (334)
Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang+7 more
wiley +1 more source
A Bioengineered In Vitro Model to Assess AAV-Based Gene Therapies for Cyclic GMP-Related Disorders. [PDF]
Pavlou M, Babutzka S, Michalakis S.
europepmc +1 more source
Inhibition of chemotaxis Ng-monomethyl-L-arginine: a role for cyclic GMP [PDF]
SS Kaplan+5 more
openalex +1 more source
ABSTRACT The ICH Q14 guideline introduces a structured framework for analytical method development based on Analytical Quality by Design (AQbD) principles, aiming to ensure robust, reliable, and fit‐for‐purpose methods throughout the product lifecycle.
Ewoud van Tricht+1 more
wiley +1 more source
BdGUCD1 and Cyclic GMP Are Required for Responses of Brachypodium distachyon to Fusarium pseudograminearum in the Mechanism Involving Jasmonate. [PDF]
Duszyn M+4 more
europepmc +1 more source
Localization of cyclic GMP-dependent protein kinase and substrate in mammalian cerebellum. [PDF]
D Schlichter+4 more
openalex +1 more source
The engineered bacteria (2'3'‐cGAMP@E.coli) is designed to synthesize intracellular 2'3'‐cGAMP, enabling the assembly of personalized nanovaccines (nECTs) through a bioconjugation with autologous tumor antigens, circumventing elaborate chemical production processes. The therapeutic impact of nECTs is significantly amplified when combined with a fasting‐
Wenping Huang+7 more
wiley +1 more source
An off-target effect of class A CpG-oligonucleotides on suppressing the cyclic GMP-AMP synthase signaling in fibroblastic reticular cells. [PDF]
Jayakumar P, Jiang T, Huang H, Deng M.
europepmc +1 more source